Express News | Keros Therapeutics Inc : Leerink Partners Cuts Target Price to $35 From $85

Breakings15:04

Small U.S. Stocks Close Lower; Keros Therapeutics Takes Biggest Hit

Dow Jones05:20

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga05:05

Keros Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones03:22 · Ratings

Top Midday Decliners

MT Newswires03:13

Keros Therapeutics Prospects Still Strong Despite Cibotercept Hurdles, Wedbush Says

MT Newswires02:24